Bond Bristol Myers Squibb 1.75% ( XS1226748512 ) in EUR

Bristol Myers Squibb

86.35 % ▲

United States

XS1226748512 ( in EUR )

1.75% per year ( payment 1 time a year)

05/14/2035

05/15/2027 ( In 199 days )

Bristol Myers Squibb is a global biopharmaceutical company engaged in the research, development, and marketing of innovative medicines and biotherapeutics across various therapeutic areas, including oncology, cardiovascular disease, immunology, and fibrosis.

Bristol Myers Squibb's EUR-denominated bond (ISIN: XS1226748512), maturing on May 14, 2035, currently trades at 87.51% of its face value, offering a 1.75% coupon rate with annual payments.

Date	Clean price
03/10/2026	86.35%
01/05/2026	84.42%
11/06/2025	85.84%
09/11/2025	85.90%
07/18/2025	85.70%
05/19/2025	84.76%
03/04/2025	86.69%
01/12/2025	84.98%
11/15/2024	87.51%
09/27/2024	87.37%
08/10/2024	86.74%
08/07/2024	100.00%
02/20/2024	85.47%
08/19/2023	92.85%
07/26/2023	92.85%
07/02/2023	92.85%
06/08/2023	92.85%
05/15/2023	92.85%
04/21/2023	92.85%
03/28/2023	92.85%
03/04/2023	92.85%
02/09/2023	92.85%
01/17/2023	92.85%
12/25/2022	92.85%
12/02/2022	92.85%
11/09/2022	92.85%
10/19/2022	92.85%
09/28/2022	92.85%
09/07/2022	92.85%
08/17/2022	92.85%
07/27/2022	92.85%
07/06/2022	92.85%
06/15/2022	92.85%
05/25/2022	92.85%
05/04/2022	92.85%
04/19/2022	95.45%
04/04/2022	99.16%
03/20/2022	98.96%
03/05/2022	102.42%
02/17/2022	101.92%
01/30/2022	108.55%
01/12/2022	109.52%
12/26/2021	111.74%
12/10/2021	113.39%
11/23/2021	112.32%
11/09/2021	113.58%
10/26/2021	111.66%
10/12/2021	110.93%
09/29/2021	112.65%
09/10/2021	114.63%
08/27/2021	115.57%
08/15/2021	117.05%
08/03/2021	117.34%
07/22/2021	116.19%
07/09/2021	115.29%
06/24/2021	113.17%
06/10/2021	114.37%
05/23/2021	110.94%
05/06/2021	113.97%
04/16/2021	114.73%
03/30/2021	114.35%
03/13/2021	115.19%
02/25/2021	115.69%
02/09/2021	118.69%
01/27/2021	120.67%
01/15/2021	119.94%
01/04/2021	120.71%
12/22/2020	120.49%
12/08/2020	120.70%
11/25/2020	120.45%
11/09/2020	119.38%
10/28/2020	119.70%